Strides Pharma Science Limited Total Assets
Strides Pharma Science Limited total assets. Based on the latest financial reports, Strides Pharma Science Limited (STAR) holds total assets worth Rs69.27 Billion INR (≈ $749.15 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Strides Pharma Science Limited market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Strides Pharma Science Limited (2005–2026)
Total assets of Strides Pharma Science Limited from 2005 to 2026. This chart illustrates how Strides Pharma Science Limited's total assets have evolved over time, based on quarterly financial data. See Strides Pharma Science Limited (STAR) stock price for real-time trading data and today's change.
Strides Pharma Science Limited - Asset Composition Analysis
Strides Pharma Science Limited Total Assets Breakdown (March 2026)
Strides Pharma Science Limited total assets breakdown as of March 2026. Strides Pharma Science Limited's total assets of Rs69.27 Billion consist of 52.2% current assets and 47.9% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 3.1% |
| Accounts Receivable | Rs12.97 Billion | 18.7% |
| Inventory | Rs16.35 Billion | 23.6% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs8.00 Billion | 11.5% |
| Goodwill | Rs5.94 Billion | 8.6% |
Asset Composition Trend (2005–2026)
This chart illustrates how Strides Pharma Science Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Strides Pharma Science Limited to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Strides Pharma Science Limited's current assets represent 52.2% of total assets in 2026, an increase from 47.1% in 2005.
- Cash Position: Cash and equivalents constituted 3.1% of total assets in 2026, down from 4.4% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 4.0% in 2005.
- Asset Diversification: The largest asset category is inventory at 23.6% of total assets.
Strides Pharma Science Limited Competitors by Total Assets
Key competitors of Strides Pharma Science Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Sandoz Group AG
SW:SDZ
|
Switzerland | CHF22.86 Billion |
|
H Lundbeck A/S
CO:HLUN-B
|
Denmark | Dkr54.01 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Viyash Scientific Limited
NSE:SEQUENT
|
India | Rs17.26 Billion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥5.11 Billion |
Strides Pharma Science Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.25 | 1.20 | 1.03 |
| Quick Ratio | 0.68 | 0.70 | 0.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs7.17 Billion | Rs5.07 Billion | Rs814.64 Million |
Strides Pharma Science Limited - Advanced Valuation Insights
This section examines the relationship between Strides Pharma Science Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.63 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 14.5% |
| Total Assets | Rs69.27 Billion |
| Market Capitalization | $1.01 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Strides Pharma Science Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Strides Pharma Science Limited's assets grew by 14.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Strides Pharma Science Limited (2005–2026)
The table below shows the annual total assets of Strides Pharma Science Limited from 2005 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs69.27 Billion ≈ $749.15 Million |
+14.52% |
| 2025-03-31 | Rs60.49 Billion ≈ $654.15 Million |
+3.58% |
| 2024-03-31 | Rs58.40 Billion ≈ $631.55 Million |
-12.03% |
| 2023-03-31 | Rs66.38 Billion ≈ $717.92 Million |
-4.84% |
| 2022-03-31 | Rs69.76 Billion ≈ $754.41 Million |
-0.56% |
| 2021-03-31 | Rs70.15 Billion ≈ $758.65 Million |
+14.03% |
| 2020-03-31 | Rs61.52 Billion ≈ $665.29 Million |
-23.16% |
| 2019-03-31 | Rs80.06 Billion ≈ $865.77 Million |
+22.34% |
| 2018-03-31 | Rs65.44 Billion ≈ $707.68 Million |
-19.38% |
| 2017-03-31 | Rs81.17 Billion ≈ $877.80 Million |
+5.98% |
| 2016-03-31 | Rs76.59 Billion ≈ $828.30 Million |
+208.08% |
| 2015-03-31 | Rs24.86 Billion ≈ $268.86 Million |
+18.44% |
| 2014-03-31 | Rs20.99 Billion ≈ $227.00 Million |
-56.25% |
| 2013-03-31 | Rs47.98 Billion ≈ $518.84 Million |
-12.20% |
| 2012-03-31 | Rs54.64 Billion ≈ $590.93 Million |
+21.61% |
| 2011-03-31 | Rs44.93 Billion ≈ $485.94 Million |
+39.12% |
| 2010-03-31 | Rs32.30 Billion ≈ $349.29 Million |
+38.77% |
| 2009-03-31 | Rs23.27 Billion ≈ $251.70 Million |
+14.46% |
| 2008-03-31 | Rs20.33 Billion ≈ $219.91 Million |
+65.73% |
| 2007-03-31 | Rs12.27 Billion ≈ $132.69 Million |
+31.10% |
| 2006-03-31 | Rs9.36 Billion ≈ $101.22 Million |
+71.20% |
| 2005-03-31 | Rs5.47 Billion ≈ $59.12 Million |
-- |
About Strides Pharma Science Limited
Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasalsprays, topical formulations, an… Read more